{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:39:39Z","timestamp":1782441579408,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200335"],"award-info":[{"award-number":["82200335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300408"],"award-info":[{"award-number":["82300408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762875"],"award-info":[{"award-number":["2024M762875"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03361-z","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:15:33Z","timestamp":1759166133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fibulin 5 mediates pulmonary artery smooth muscle cell dysfunction and vascular remodelling in congenital heart disease associated pulmonary arterial hypertension via TGF-\u03b21\/PI3K\/AKT signalling"],"prefix":"10.1186","volume":"26","author":[{"given":"Jing-Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ling","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"3361_CR1","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","volume":"39","author":"JI Hoffman","year":"2002","unstructured":"Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890\u2013900.","journal-title":"J Am Coll Cardiol"},{"key":"3361_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/hrt.2006.098848","volume":"93","author":"PM Engelfriet","year":"2007","unstructured":"Engelfriet PM, Duffels MG, Moller T, Boersma E, Tijssen JG, Thaulow E, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro heart survey on adult congenital heart disease. Heart. 2007;93:682\u20137.","journal-title":"Heart"},{"key":"3361_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","volume":"120","author":"MG Duffels","year":"2007","unstructured":"Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, van der Velde ET, Bresser P, Mulder BJ. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120:198\u2013204.","journal-title":"Int J Cardiol"},{"key":"3361_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2217\/fca-2017-0065","volume":"14","author":"E Pascall","year":"2018","unstructured":"Pascall E, Tulloh RM. Pulmonary hypertension in congenital heart disease. Future Cardiol. 2018;14:343\u201353.","journal-title":"Future Cardiol"},{"key":"3361_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","volume":"18","author":"D Heath","year":"1958","unstructured":"Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533\u201347.","journal-title":"Circulation"},{"key":"3361_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","volume":"35","author":"A Manes","year":"2014","unstructured":"Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galie N. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35:716\u201324.","journal-title":"Eur Heart J"},{"key":"3361_CR7","doi-asserted-by":"publisher","first-page":"22476","DOI":"10.1074\/jbc.274.32.22476","volume":"274","author":"T Nakamura","year":"1999","unstructured":"Nakamura T, Ruiz-Lozano P, Lindner V, Yabe D, Taniwaki M, Furukawa Y, et al. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem. 1999;274:22476\u201383.","journal-title":"J Biol Chem"},{"key":"3361_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1161\/01.RES.84.10.1166","volume":"84","author":"RC Kowal","year":"1999","unstructured":"Kowal RC, Richardson JA, Miano JM, Olson EN. EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ Res. 1999;84:1166\u201376.","journal-title":"Circ Res"},{"key":"3361_CR9","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1073\/pnas.0500058102","volume":"102","author":"JA Spencer","year":"2005","unstructured":"Spencer JA, Hacker SL, Davis EC, Mecham RP, Knutsen RH, Li DY, et al. Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A. 2005;102:2946\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3361_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2045893218755987","volume":"8","author":"L Huang","year":"2018","unstructured":"Huang L, Li L, Hu E, Chen G, Meng X, Xiong C, et al. Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study. Pulm Circ. 2018;8:2045893218755987.","journal-title":"Pulm Circ"},{"issue":"6","key":"3361_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/104454904323145254","volume":"23","author":"AR Albig","year":"2004","unstructured":"Albig AR, Schiemann WP. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol. 2004;23(6):367\u201379.","journal-title":"DNA Cell Biol"},{"key":"3361_CR12","doi-asserted-by":"publisher","first-page":"27367","DOI":"10.1074\/jbc.M200148200","volume":"277","author":"WP Schiemann","year":"2002","unstructured":"Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE\/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem. 2002;277:27367\u201377.","journal-title":"J Biol Chem"},{"key":"3361_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1164\/rccm.201607-1515PP","volume":"195","author":"S Bonnet","year":"2017","unstructured":"Bonnet S, Provencher S, Guignabert C, Perros F, Boucherat O, Schermuly RT, Hassoun PM, Rabinovitch M, Nicolls MR, Humbert M. Translating research into improved patient care in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2017;195:583\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"3361_CR14","doi-asserted-by":"crossref","unstructured":"Zhou JJ, Li H, Li L, Li Y, Wang PH, Meng XM, He JG. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension. J Cell Physiol. 2021;236:6297\u2013311.","DOI":"10.1002\/jcp.30298"},{"key":"3361_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yjmcc.2020.09.005","volume":"149","author":"JJ Zhou","year":"2020","unstructured":"Zhou JJ, Li H, Qian YL, Quan RL, Chen XX, Li L, Li Y, Wang PH, Meng XM, Jing XL, He JG. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease. J Mol Cell Cardiol. 2020;149:41\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"3361_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jtcvs.2013.01.018","volume":"146","author":"L Meng","year":"2013","unstructured":"Meng L, Liu X, Zheng Z, Li J, Meng J, Wei Y, et al. Original rat model of high kinetic unilateral pulmonary hypertension surgically induced by combined surgery. J Thorac Cardiovasc Surg. 2013;146:1220-e12261221.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3361_CR17","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","volume":"69","author":"M Guazzi","year":"2017","unstructured":"Guazzi M, Naeije R. Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol. 2017;69:1718\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"3361_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.pupt.2010.02.003","volume":"23","author":"T Kuang","year":"2010","unstructured":"Kuang T, Wang J, Pang B, Huang X, Burg ED, Yuan JX, et al. Combination of sildenafil and Simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats. Pulm Pharmacol Ther. 2010;23:456\u201364.","journal-title":"Pulm Pharmacol Ther"},{"key":"3361_CR19","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/carcin\/bgn199","volume":"29","author":"YH Lee","year":"2008","unstructured":"Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis. 2008;29:2243\u201351.","journal-title":"Carcinogenesis"},{"key":"3361_CR20","doi-asserted-by":"publisher","first-page":"L848","DOI":"10.1152\/ajplung.00319.2003","volume":"286","author":"J Wang","year":"2004","unstructured":"Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2004;286:L848\u2013858.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3361_CR21","doi-asserted-by":"crossref","unstructured":"Huetsch JC, Suresh K, Shimoda LA. Regulation of smooth muscle cell proliferation by NADPH oxidases in pulmonary hypertension. Antioxid (Basel). 2019;8:56.","DOI":"10.3390\/antiox8030056"},{"key":"3361_CR22","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20165526","volume":"49","author":"SD Chai","year":"2016","unstructured":"Chai SD, Liu T, Dong MF, Li ZK, Tang PZ, Wang JT, et al. Inactivated Pseudomonas aeruginosa inhibits hypoxia-induced pulmonary hypertension by preventing TGF-beta1\/Smad signaling. Braz J Med Biol Res. 2016;49:e5526.","journal-title":"Braz J Med Biol Res"},{"key":"3361_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2017.12.010","volume":"820","author":"N Zhang","year":"2018","unstructured":"Zhang N, Dong M, Luo Y, Zhao F, Li Y. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-\u03b2-smad3-associated pathway. Eur J Pharmacol. 2018;820:1\u20137.","journal-title":"Eur J Pharmacol"},{"key":"3361_CR24","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3892\/mmr.2016.4874","volume":"13","author":"L Li","year":"2016","unstructured":"Li L, Zhang X, Li X, Lv C, Yu H, Xu M, et al. TGF-\u03b21 inhibits the apoptosis of pulmonary arterial smooth muscle cells and contributes to pulmonary vascular medial thickening via the PI3K\/Akt pathway. Mol Med Rep. 2016;13:2751\u20136.","journal-title":"Mol Med Rep"},{"key":"3361_CR25","doi-asserted-by":"publisher","first-page":"C24","DOI":"10.1152\/ajpcell.00295.2015","volume":"311","author":"P Abeyrathna","year":"2016","unstructured":"Abeyrathna P, Kovacs L, Han W, Su Y. Calpain-2 activates Akt via TGF-\u03b21-mTORC2 pathway in pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol. 2016;311:C24\u201334.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3361_CR26","doi-asserted-by":"publisher","first-page":"17838","DOI":"10.1002\/jcb.29051","volume":"120","author":"Y Chen","year":"2019","unstructured":"Chen Y, Li J, Jin L, Lei K, Liu H, Yang Y. Fibulin-5 contributes to colorectal cancer cell apoptosis via the ROS\/MAPK and Akt signal pathways by downregulating transient receptor potential cation channel subfamily V member 1. J Cell Biochem. 2019;120:17838\u201346.","journal-title":"J Cell Biochem"},{"key":"3361_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/01.RES.0000182425.49768.8a","volume":"97","author":"SL Merklinger","year":"2005","unstructured":"Merklinger SL, Wagner RA, Spiekerkoetter E, Hinek A, Knutsen RH, Kabir MG, et al. Increased fibulin-5 and Elastin in S100A4\/Mts1 mice with pulmonary hypertension. Circ Res. 2005;97:596\u2013604.","journal-title":"Circ Res"},{"key":"3361_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molmed.2016.11.005","volume":"23","author":"AAR Thompson","year":"2017","unstructured":"Thompson AAR, Lawrie A. Targeting vascular remodeling to treat pulmonary arterial hypertension. Trends Mol Med. 2017;23:31\u201345.","journal-title":"Trends Mol Med"},{"key":"3361_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1165\/rcmb.2012-0049OC","volume":"48","author":"T Ogo","year":"2013","unstructured":"Ogo T, Chowdhury HM, Yang J, Long L, Li X, Torres Cleuren YN, et al. Inhibition of overactive transforming growth factor-\u03b2 signaling by prostacyclin analogs in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2013;48:733\u201341.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3361_CR30","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1165\/rcmb.2012-0470OC","volume":"49","author":"PD Upton","year":"2013","unstructured":"Upton PD, Davies RJ, Tajsic T, Morrell NW. Transforming growth factor-\u03b2(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3. Am J Respir Cell Mol Biol. 2013;49:1135\u201345.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3361_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.108.821504","volume":"119","author":"L Long","year":"2009","unstructured":"Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, et al. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation. 2009;119:566\u201376.","journal-title":"Circulation"},{"key":"3361_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","volume":"174","author":"M Thomas","year":"2009","unstructured":"Thomas M, Docx C, Holmes AM, Beach S, Duggan N, England K, et al. Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline. Am J Pathol. 2009;174:380\u20139.","journal-title":"Am J Pathol"},{"key":"3361_CR33","doi-asserted-by":"crossref","unstructured":"Bellaye PS, Yanagihara T, Granton E, Sato S, Shimbori C, Upagupta C, Imani J, Hambly N, Ask K, Gauldie J, et al. Macitentan reduces progression of TGF-\u03b21-induced pulmonary fibrosis and pulmonary hypertension. Eur Respir J. 2018;52:1701857.","DOI":"10.1183\/13993003.01857-2017"},{"key":"3361_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s12276-018-0068-3","volume":"50","author":"Z Cai","year":"2018","unstructured":"Cai Z, Li J, Zhuang Q, Zhang X, Yuan A, Shen L, Kang K, Qu B, Tang Y, Pu J, et al. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-beta1 and IL-6\/STAT3 signaling pathways. Exp Mol Med. 2018;50:45.","journal-title":"Exp Mol Med"},{"key":"3361_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/BJ20070400","volume":"405","author":"AC Lomas","year":"2007","unstructured":"Lomas AC, Mellody KT, Freeman LJ, Bax DV, Shuttleworth CA, Kielty CM. Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activation. Biochem J. 2007;405:417\u201328.","journal-title":"Biochem J"},{"key":"3361_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1042\/BJ20110348","volume":"443","author":"A Kapustin","year":"2012","unstructured":"Kapustin A, Stepanova V, Aniol N, Cines DB, Poliakov A, Yarovoi S, et al. Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated \u03b21-integrin-dependent cell migration. Biochem J. 2012;443:491\u2013503.","journal-title":"Biochem J"},{"key":"3361_CR37","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3892\/ijo.2016.3394","volume":"48","author":"Y Mohamedi","year":"2016","unstructured":"Mohamedi Y, Fontanil T, Solares L, Garcia-Su\u00e1rez O, Garc\u00eda-Piqueras J, Vega JA, et al. Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells. Int J Oncol. 2016;48:1447\u201356.","journal-title":"Int J Oncol"},{"key":"3361_CR38","doi-asserted-by":"publisher","first-page":"L489","DOI":"10.1152\/ajplung.90488.2008","volume":"296","author":"S Ismail","year":"2009","unstructured":"Ismail S, Sturrock A, Wu P, Cahill B, Norman K, Huecksteadt T, et al. Nox4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol. 2009;296:L489-499.","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03361-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:15:35Z","timestamp":1759166135000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03361-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03361-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical data analysis was approved by the Ethics Committee of Fuwai Hospital. All animal experiments were authorized by the Institutional Animal Care and Use Committee of Fuwai Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}